TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/VXL

Vaxil Bio Ltd (VXL : TSX-V)

Common Stock

$0.14

CAD

+0.00 (%)

Last updated: 2026-09-17

Follow VXL

VXL

Vaxil Bio Ltd

Source:WealthAwesomeWealthAwesome
$0.04 (-19.44%)
30 day period
$0.14$0.16$0.18Jun 15Jul 10Sep 17

Performance

1 Day

+0.00%

1 Week

+0.00%

1 Month

-9.38%

YTD

+0.00%

Key Statistics

Market Cap

$577,682

52W High

$0.29

52W Low

$0.13

P/E Ratio

0.97

50 Day MA

$0.16

200 Day MA

$0.17

Beta

-0.87

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/17/2026$0.14$0.14$0.14$0.14$0.14500
9/15/2026$0.15$0.15$0.14$0.14$0.143,000
9/14/2026$0.15$0.15$0.15$0.15$0.15504
9/11/2026$0.15$0.15$0.15$0.15$0.15500
9/10/2026$0.15$0.15$0.15$0.15$0.153,500
9/8/2026$0.16$0.16$0.16$0.16$0.1620,610
9/4/2026$0.17$0.17$0.17$0.17$0.172,000
8/31/2026$0.18$0.18$0.17$0.17$0.1712,110
8/26/2026$0.16$0.16$0.16$0.16$0.164,040
8/18/2026$0.16$0.16$0.16$0.16$0.161,200

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on VXL's historical volatility

HistoricalForecast68%95%
C$0.05C$0.10C$0.15C$0.20C$0.26C$0.31TodayMar 18May 25Sep 17Oct 30Dec 13Jan 25

30-Day Vol

75.6%

Annualized

90-Day Vol

108.4%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.12

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.14C$0.11C$0.18
60 trading daysC$0.13C$0.09C$0.19
90 trading daysC$0.12C$0.08C$0.19

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Vaxil Bio Ltd

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-252,000
Profit Margin
0.00%
ROE (TTM)
39.89%
EPS (Diluted)
0.15
Book Value
0.32

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About VXL

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
ESXREssex Resources Corp.$0.40+182.14%
RCR-PCanna 8 Investment Trust$0.01+100.00%
BARKBlack Spruce Exploration Inc.$0.04+50.00%
AUGCAu Gold Corp$0.27+38.46%
TIEColoured Ties Capital Inc$1.16+36.47%
GWMGalway Metals Inc.$0.89+34.85%
FRNTFRNT Financial Inc$0.04+33.33%
SNVSonoro Energy Ltd$0.02+33.33%

VXL.V news timeline

8 articles covering VXL.V, most recent first

Latest

What's Going On With Vaxil Bio Ltd Stock Friday?

Stocks

Advertisement